申请人:Sanofi Winthrop, Inc.
公开号:US05656629A1
公开(公告)日:1997-08-12
6-Substituted pyrazolo[3,4 -d]pyrimidin-4-one derivatives, pharmaceutical compositions containing them and methods for effecting c-GMP-phosphodiesterase inhibition and for treating heart failure and/or hypertension.
6-取代嘧啶并[3,4 -d]嘧啶-4-酮衍生物,含有它们的药物组合物以及用于影响c-GMP-磷酸二酯酶抑制和治疗心力衰竭和/或高血压的方法。